Completed PHASE1 INTERVENTIONAL NCT04096001

Woebot for Substance Use Disorders

RCT of Woebot for Substance Use Disorders Phase 1

Sponsor: Stanford University

Updated 11 times since 2019 Last updated: Aug 8, 2022 Started: Mar 26, 2020 Primary completion: Aug 31, 2020 Completion: Aug 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04096001, this PHASE1 trial focuses on Substance Use Disorders and remains completed. Sponsored by Stanford University, it has been updated 11 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2023 — Jul 2024 [monthly]

Completed PHASE1
Dec 2022 — Jan 2023 [monthly]

Completed PHASE1
Sep 2022 — Dec 2022 [monthly]

Completed PHASE1

▶ Show 6 earlier versions

Sep 2021 — Sep 2022 [monthly]

Completed PHASE1
Jan 2021 — Sep 2021 [monthly]

Completed PHASE1
Oct 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Sep 2020 — Oct 2020 [monthly]

Recruiting PHASE1

Phase: None → PHASE1
May 2020 — Sep 2020 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Oct 2019 — May 2020 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stanford University
Woebot Health

Data source: Woebot Health

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States